Research reportVentrolateral periaqueductal gray lesion attenuates nociception but does not change anxiety-like indices or fear-induced antinociception in mice
Research highlights
▶ Ventrolateral PAG lesion does not alter anxiety in mice. ▶ Ventrolateral PAG does not attenuate fear-induced antinociception. ▶ Ventrolateral PAG lesion attenuates pain in mice exposed to a non-aversive situation. ▶ Ventrolateral PAG plays a role in general activity in mice.
Introduction
Reynolds [1] was the first to report that electrical stimulation of the midbrain periaqueductal gray (PAG) produces pain inhibition. Since then, many studies have characterized the PAG as an important structure of the descending pain inhibitory system [for a review, see Ref. [2]]. The effect elicited by PAG stimulation on nociception involves modulation of the nociceptive transmission in the spinal cord, a role that seems to depend on the rostral ventromedial medulla (RVM) function, since RVM lesion abolishes this type of pain inhibition [2], [3], [4].
The PAG is anatomically and functionally organized, being divided into four longitudinal parts that run parallel to the aqueduct, viz. the dorsomedial, dorsolateral, lateral and ventrolateral columns [5], [6]. Chemical or electrical stimulation of dorsolateral and lateral PAG (dlPAG and lPAG) causes vigorous somatomotor activity, sympathoexcitation, cardio respiratory alterations and short-term non-opioid mediated analgesia [3], [5], [7], [8], [9], [10], [11]. On the other hand, the stimulation of the ventrolateral PAG (vlPAG) evokes “conservation-withdrawal” strategies or a passive coping reaction of quiescence/immobility, decreased vigilance and hyporeactivity, hypotension, bradycardia and an opioid analgesia which has a relatively long time course [5], [6], [7], [9], [10], [11], [12], [13].
It has been shown that PAG also participates in some types of environmentally induced analgesia [9], [14], [15], [16], [17]. Concerning the fact that animals display pain inhibition when confronted with threatening situations, Bolles and Fanselow [18] emphasized that this reaction has a clear adaptive value, since it gives the animal an opportunity to exhibit defensive behavior, even though an injury has occurred, thereby increasing its chances of survival. Thus, considered to be an important structure of the brain defensive system (e.g., Ref. [19], [20]), the PAG also participates in some types of aversive situation-induced antinociception.
It has been demonstrated that exposure of rodents to an elevated plus-maze (EPM: an apparatus in the shape of a plus sign, with two open and two enclosed arms, each with an open roof, elevated from the floor), a widely used animal model of anxiety [for a review, see Ref. [21]], besides inducing defensive behavioral responses, also elicits antinociception [22], [23], [24], [25]. In experiments carried out in our laboratory, EPM-exposed mice do not display intense antinociception, assessed by the formalin nociception test. Nevertheless, when placed in a totally open elevated plus-maze (oEPM: with four open arms) mice [26], [27] and rats [28] exhibit an intense antinociceptive response.
In order to investigate the role played by the dorsal portion of the PAG (dPAG: dm and dl columns) on oEPM-induced antinociception, we lesioned the dPAG by injecting a high dose of NMDA (N-methyl-d-aspartate) into this site. Bilateral dPAG lesion did not change oEPM-induced antinociception, but attenuated anxiety-like behavior in mice exposed to a standard EPM (sEPM: two open and two enclosed arms) [27]. Given that the vlPAG also modulates some forms of environmentally induced antinociception [9], [14], [16], [17], [29], the present study investigated the role of vlPAG on oEPM-induced antinociception and on sEPM-induced anxiety-like behavior in mice. To this end, a bilateral lesion was induced in the vlPAG by an injection of NMDA. The formalin test was used to assess nociception in the mice and was specifically chosen since it permits the assessment of pain sensitivity concurrently with exposure to an aversive situation, namely the oEPM.
Section snippets
Subjects
The subjects were male Swiss mice (São Paulo State University/UNESP, SP, Brazil), weighing 25–35 g. They were housed in groups of 7 per cage (41 cm × 34 cm × 16 cm) and maintained under a 12:12 h light/dark cycle (lights on at 7:00 a.m.) in a temperature (23 ± 1 °C) and humidity (55 ± 5%) controlled environment. Food and drinking water were freely available. All mice were experimentally naive, and experimental sessions were carried out during the light phase of the cycle (9 a.m.–5 p.m.).
Drugs
NMDA (N-methyl-d
Histology
All NMDA and sham lesions were verified histologically with Nissl staining. Similarly to previously described electrolytic [41] and chemical [27], [42] lesions of PAG, the lesion areas were extensive (see Figs. 1B and 2). In some cases, they included the lateral part of the PAG (lPAG) and also extended dorsally into the superior and/or inferior colliculi. The dorsal part of the PAG (dPAG, i.e. dorsolateral and dorsomedial columns), however, was left intact. There was no sign of lesion in the
Discussion
The results showed that oEPM-induced antinociception was not altered by bilateral lesion of vlPAG in mice. Surprisingly, vlPAG lesion decreased the nociception response in eEPM-exposed mice and increased locomotor activity in both eEPM and oEPM exposed-groups. Furthermore, in contrast to previously observed results with dPAG lesion [27], bilateral vlPAG lesion did not produce anxiolytic-like effects in sEPM-exposed animals that had not received a formalin injection.
Although the PAG has been
Acknowledgements
We thank Tatiani Sorregotti, Elisabete Zocal Paro Lepera, Rosana Finoti Pupim Silva and Cláudia Solano Rocha for the excellent technical assistance. This study was supported by FAPESP, CNPq and PADC/FCF-UNESP. J. Mendes-Gomes was supported by a FAPESP fellowship (05/01988-3), V.C.S. Amaral by a CNPq fellowship (142266/2008-6) and R.L. Nunes-de-Souza received a CNPq research fellowship (309407/2006-0).
References (69)
Functional characteristics of the midbrain periaqueductal gray
Prog Neurobiol
(1995)- et al.
Descending control of nociception: specificity, recruitment and plasticity
Brain Res Rev
(2009) - et al.
Columnar organization in midbrain periaqueductal gray: modules for emotional expression?
Trends Neurosci
(1994) The periaqueductal gray and defensive behavior: functional representation and neuronal organization
Behav Brain Res
(1993)- et al.
Parallel circuits mediating distinct emotional coping reactions to different types of stress
Neurosci Biobehav Rev
(2001) Integrated activity of cardiovascular and pain regulatory systems: role in adaptative behavioral responses
Prog Neurobiol
(1993)Descending antinociceptive mechanisms in the brainstem: their role in the animal's defensive system
J Physiol Paris
(1996)- et al.
An ethological model for the study of activation and interaction of pain, memory and defensive systems in the attacked mouse. Role of endogenous opioids
Neurosci Biobehav Rev
(1990) Serotonin, the periaqueductal gray and panic
Neurosci Biobehav Rev
(2004)- et al.
temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 years on
Neurosci Biobehav Rev
(2005)